Clinical Uncertainty Budgets: Health AI Be Allowed Before It Recommends Action

Artificial intelligence is increasingly being used to interpret medical images, estimate disease risks, analyze laboratory results, monitor chronic conditions, and support clinical decisions. These systems can identify patterns across large datasets and generate predictions that may help healthcare professionals recognize problems earlier. However, even a highly capable health AI cannot eliminate uncertainty. Its predictions may be affected by incomplete records, noisy measurements, unusual patient characteristics, conflicting clinical evidence, or changes in the population in which the model operates.

This creates a difficult question for healthcare: how much uncertainty should an AI system be allowed to tolerate before it recommends an action?

A model might estimate that a patient faces an elevated risk of a particular condition, but the prediction may be based on incomplete information. Another system might detect an abnormal pattern in a medical image while remaining unsure whether it represents a serious disease or a harmless variation. In each situation, the system must determine whether to recommend immediate evaluation, request additional information, continue monitoring, or refrain from making a recommendation.

The answer cannot depend on prediction confidence alone. A moderately uncertain alert about a potentially life-threatening condition may be justified because the consequences of missing the condition are severe. The same level of uncertainty may be unacceptable when the proposed action involves a risky treatment, an invasive procedure, or a medication change that could harm the patient. Clinical Uncertainty Budgets offer a framework for thinking about these decisions.

This approach could help make healthcare AI safer, more transparent, and more useful. Its purpose is not to eliminate uncertainty before every decision, which would often be impossible, but to determine when uncertainty is acceptable, when further investigation is necessary, and when an automated system should defer to a qualified healthcare professional.

Understanding Clinical Uncertainty Budgets

What Is a Clinical Uncertainty Budget?

A clinical uncertainty budget is a proposed decision-making framework that defines how much unresolved uncertainty may be acceptable before a health AI recommends a particular action. The budget depends on the nature of the decision, the potential consequences of an incorrect recommendation, and the strength of the available evidence.

In conventional machine learning, uncertainty may be represented through prediction intervals, probability estimates, confidence measures, or disagreement among multiple models. These techniques can help describe what a system does not know, but they do not independently determine whether a clinical action is appropriate. A probability estimate becomes meaningful for decision-making only when it is interpreted in relation to the possible outcomes and the risks of acting or waiting.

For example, a health AI might identify a possible abnormality and estimate that further investigation is warranted despite uncertainty about the underlying diagnosis. The appropriate action may be to arrange a clinical assessment rather than declare that a disease is present. By contrast, a system considering whether to recommend a high-risk intervention would need stronger evidence and more rigorous safeguards.

The uncertainty budget therefore should not be understood as one universal numerical threshold. It is better viewed as a decision-specific tolerance for uncertainty, supported by clinical evidence, risk assessment, and appropriate oversight.

Why One Confidence Threshold Cannot Govern Every Medical Decision

Many AI systems produce a score that appears to represent the likelihood of a particular outcome. It can be tempting to establish a single threshold above which the system recommends action and below which it remains silent. However, medical decisions differ substantially in their consequences.

A screening alert may be designed to identify people who should receive further testing. Missing a serious condition could delay diagnosis, while a false alert may lead to additional testing and temporary anxiety. In such a context, a relatively sensitive approach may be justified if confirmatory testing is available.

A medication recommendation presents a different problem. Acting on an incorrect prediction may expose a patient to adverse effects, interactions, or complications. An invasive procedure can carry even greater consequences, making a simple confidence score inadequate for deciding whether intervention is appropriate.

Clinical Uncertainty Budgets recognize that the acceptable level of uncertainty must depend on the action being considered. The system may reasonably recommend a low-risk information-gathering step under conditions where it should not recommend treatment. This distinction creates a more nuanced relationship between AI predictions and clinical decisions.

The Different Sources of Uncertainty in Health AI

Data Uncertainty: When the Patient Record Is Incomplete

Clinical AI systems frequently operate with incomplete information. A patient record may contain missing laboratory results, outdated medication lists, inconsistent observations, or measurements collected using different equipment. Some patients may have limited medical histories, while others may have extensive records spanning several years.

These gaps create uncertainty because the model must interpret the available evidence without knowing whether the missing information would change its conclusion. A prediction based on a complete record may therefore be more dependable than an apparently similar prediction based on only a few observations.

Clinical Uncertainty Budgets could account for this distinction by evaluating the quality and completeness of the information supporting a recommendation. If essential data are missing, the system might request the relevant measurement, recommend professional review, or limit itself to a less consequential suggestion. It should not automatically treat missing information as evidence that a risk is absent.

However, missing data do not always make a recommendation impossible. In urgent situations, clinicians may need to act before every relevant test is available. The objective is to communicate the limitations of the available evidence and determine whether the risks of waiting exceed the risks of acting.

Model Uncertainty: When the AI Does Not Know Enough

Model uncertainty arises when an AI system lacks sufficient knowledge to make a dependable prediction. This may occur when the training dataset contains too few comparable cases, when the patient’s characteristics differ substantially from those represented during development, or when the model encounters a clinical situation it has not learned to interpret reliably.

For instance, an AI system trained primarily on adults from a particular healthcare setting may perform less reliably when analyzing data from children, older adults with multiple conditions, or patients receiving unfamiliar treatments. Even if the system produces a numerical prediction, that number may not accurately reflect its actual reliability in the new context.

Researchers often distinguish uncertainty associated with incomplete knowledge from uncertainty arising from inherent variability in the process being measured. This distinction can help determine whether collecting more information is likely to improve the prediction. However, no single uncertainty-estimation technique works equally well across all clinical applications.

A well-designed system should therefore be evaluated for its ability to recognize situations outside its validated scope. When evidence is insufficient, the system should be able to abstain from a definitive recommendation, request additional assessment, or transfer the decision to a qualified professional.

Biological Uncertainty: When Human Responses Differ

Human biology introduces uncertainty even when measurements are accurate and the model is operating as intended. Two patients with similar laboratory results may respond differently to the same medication or lifestyle intervention because of genetic differences, coexisting conditions, age, physiology, environmental influences, or treatment history.

A model trained on population averages may fail to capture these individual differences. It might predict that an intervention is likely to help most patients with a particular profile, while overlooking a characteristic that changes the expected response for one individual.

Clinical Uncertainty Budgets must therefore account for the distinction between uncertainty caused by limited data and variation that persists across individuals. More data may reduce some uncertainty, but it cannot guarantee that every biological response will become predictable.

This is particularly important in personalized medicine. The goal should not be to force every patient into a single predictive model, but to determine whether the evidence supports an individualized recommendation and whether the remaining uncertainty is acceptable for the proposed action.

How an AI System Could Calculate Its Uncertainty Budget

Connecting Uncertainty to Clinical Consequences

A practical uncertainty budget would begin by identifying the decision the AI is expected to support. The system would then consider the potential benefits of acting, the harm associated with an incorrect action, and the consequences of delaying a decision.

Decision theory provides a useful foundation for this process. Rather than choosing an action solely because it has the highest predicted probability of success, a system can compare the expected consequences of different options. These consequences include potential benefits, adverse effects, missed diagnoses, unnecessary interventions, and the value of obtaining further information.

Imagine an AI system estimating whether a patient may have a serious condition. If the consequence of missing the condition is substantial and the proposed next step is a relatively low-risk clinical assessment, an alert may be justified even when the model remains uncertain about the diagnosis. If the proposed action is an invasive intervention, the evidence required to support that action would generally need to be much stronger.

This does not mean that an AI should independently make such decisions. It means the system can be designed to distinguish between recommending further assessment and recommending a consequential intervention. The acceptable uncertainty level should be established through clinical evaluation, not selected arbitrarily by the model developer.

Using Calibration to Make Probabilities Meaningful

A prediction of 80% risk is useful only if the system’s probability estimates are sufficiently calibrated. In a well-calibrated model, predictions assigned a probability of approximately 80% should correspond to the outcome occurring about 80% of the time among comparable cases, over an appropriate evaluation period.

Calibration is especially important when a health AI’s output is used to decide whether an action is warranted. A model can rank patients correctly while systematically overestimating or underestimating their absolute risks. A high-performing model may therefore still produce inappropriate recommendations if its probabilities are poorly calibrated.

Researchers can evaluate calibration using independent datasets, appropriate statistical measures, and visual comparisons between predicted and observed outcomes. They should also investigate whether calibration differs across patient groups or healthcare settings.

Even a well-calibrated probability does not automatically determine the right action. Clinical decisions also depend on the severity of the outcome, the effectiveness of available interventions, the risks of treatment, and patient preferences. Calibration makes uncertainty estimates more informative; clinical reasoning determines how those estimates should be used.

Allowing the System to Request More Evidence

One of the most valuable features of an uncertainty-aware health AI would be the ability to recognize when additional information could change its recommendation. Instead of producing an immediate answer for every case, the system could identify a missing laboratory result, recommend confirmation of a questionable measurement, or ask for clarification about a relevant symptom.

This approach connects uncertainty management with the value of information. A new test is useful when its expected contribution to the decision justifies its cost, delay, inconvenience, and potential risks. Additional data are not automatically beneficial, especially when they are unlikely to change the appropriate course of action.

For example, a model may remain uncertain because two plausible diagnoses require different investigations. In that situation, a carefully selected test could meaningfully reduce uncertainty. In another case, the model may be uncertain about a low-risk prediction, but further testing may be unnecessary because the uncertainty has little effect on the decision.

The system should therefore evaluate whether additional evidence is likely to improve the decision rather than repeatedly requesting tests until a prediction appears sufficiently confident.

Designing Different Uncertainty Budgets for Different Clinical Actions

Screening, Diagnosis, and Treatment Require Different Standards

The distinction between screening and diagnosis illustrates why uncertainty budgets must be action-specific. Screening systems are often designed to identify people who may benefit from further evaluation. Their purpose is to prioritize attention, not necessarily to establish a definitive diagnosis.

Diagnostic support requires a different approach. A model may help clinicians compare possible explanations for symptoms or test results, but its recommendation must reflect the quality of the evidence and the limitations of the diagnostic method. If multiple explanations remain plausible, the system should communicate that ambiguity rather than presenting one possibility as established fact.

Treatment recommendations introduce further considerations. An intervention may carry risks that are difficult to reverse, and its benefits may depend on details not fully captured in the available data. The system must therefore account for treatment effectiveness, contraindications, interactions, and patient-specific circumstances. Higher uncertainty may justify further assessment or professional review rather than an automated treatment recommendation. These distinctions create a graduated approach to AI assistance.

Reversible Actions Versus Irreversible Decisions

The reversibility of an action is another important factor in determining acceptable uncertainty. Some recommendations, such as scheduling a follow-up appointment or collecting a missing measurement, can usually be revised with limited direct harm. Other decisions, including certain invasive procedures or changes to critical medication regimens, may carry consequences that cannot easily be undone.

A clinical uncertainty budget should reflect this difference. When the proposed action is low-risk and reversible, acting while some uncertainty remains may be reasonable. When the action is potentially harmful or irreversible, the system should generally require stronger evidence and more rigorous safeguards.

Reversibility alone is not enough to determine whether an action is appropriate. A seemingly minor delay may be dangerous in an emergency, while an apparently reversible intervention may still cause significant harm. The framework must therefore consider urgency, clinical context, and the relative consequences of acting versus waiting.

The key principle is proportionality. The level of evidence required should correspond to the seriousness of the decision and the potential harm associated with being wrong.

Real-World Applications of Clinical Uncertainty Budgets

Emergency Medicine and Early Warning Systems

Emergency medicine involves decisions under considerable uncertainty. Clinicians may need to assess patients before complete laboratory results or imaging findings are available. An AI system could help identify patterns associated with deterioration and recommend further assessment when the potential cost of delay is high.

An uncertainty-aware system would distinguish between an early warning and a definitive diagnosis. It could flag a concerning pattern, explain which observations support the alert, and indicate whether missing information limits its assessment. The appropriate response would depend on the urgency of the situation and established clinical protocols.

However, excessive alerts can overwhelm healthcare teams and contribute to alarm fatigue. A system that repeatedly issues low-value warnings may become less useful, even if it occasionally identifies serious problems. Its uncertainty budget should therefore consider not only the cost of missed events but also the burden and consequences of unnecessary alerts.

Chronic Disease Management

People living with chronic conditions often require repeated monitoring and adjustments to their care. AI systems may analyze laboratory measurements, symptoms, medication records, and home monitoring data to identify changes that warrant attention.

An uncertainty budget could help determine when a change in a patient’s measurements is sufficiently reliable to justify a recommendation. If readings are inconsistent or the model detects a pattern outside its validated range, it could request repeat measurements or professional review rather than interpreting the change as a confirmed deterioration.

Longitudinal information may also help the system distinguish an unusual reading from a sustained change. Nevertheless, historical patterns should not override signs of an acute problem. A model must remain capable of recognizing that a new event may require immediate assessment, even when it differs from the patient’s usual profile.

Medical Imaging and Laboratory Interpretation

AI models used in medical imaging and laboratory interpretation often produce scores that represent the likelihood of an abnormality. These outputs can support clinical workflows, but a score alone does not establish whether an abnormality is present or what should happen next.

An uncertainty-aware system could consider image quality, unusual anatomical features, conflicting findings, and differences between the current case and the data used to validate the model. When uncertainty is high, it could prioritize expert review or additional testing rather than issuing a definitive interpretation.

Laboratory systems could use similar principles when results are inconsistent with previous measurements or when known physiological factors complicate interpretation. The purpose would be to identify where automated analysis is useful and where further verification is necessary.

Challenges in Implementing Clinical Uncertainty Budgets

Defining Acceptable Uncertainty Without Arbitrary Thresholds

A major challenge is determining who sets the uncertainty budget and how it should be justified. A developer may be able to measure model uncertainty, but deciding how much uncertainty is acceptable for a clinical action requires knowledge of patient outcomes, clinical practice, and the consequences of errors.

Different healthcare settings may also require different thresholds. A screening program with access to rapid confirmatory testing may operate differently from a resource-limited setting where additional tests are expensive or difficult to obtain. These differences should be explicitly considered rather than hidden inside a model’s technical settings.

Monitoring Performance After Deployment

A model’s uncertainty estimates can become unreliable when clinical practices, patient populations, equipment, or data collection methods change. This phenomenon is often described as distribution shift. A system that performed well during initial validation may encounter unfamiliar cases after deployment.

Continuous monitoring should therefore examine not only overall prediction accuracy but also calibration, subgroup performance, data quality, and the frequency of cases in which the model abstains or requests further assessment. When performance deteriorates, the system may need recalibration, additional validation, restricted use, or temporary suspension.

Healthcare organizations should also establish clear procedures for reviewing incidents in which an AI recommendation contributed to an incorrect or delayed decision. Without this feedback process, uncertainty budgets risk becoming static rules that fail to reflect changing clinical realities.

Preventing Automation Bias

Even when an AI system clearly communicates uncertainty, healthcare professionals may give its recommendation more weight than the evidence warrants. This tendency, commonly called automation bias, can cause users to overlook contradictory findings or accept an AI-generated conclusion without sufficient scrutiny.

Effective system design should make uncertainty understandable rather than burying it in technical scores. Recommendations should explain relevant limitations, identify missing evidence, and distinguish between a possible concern and a conclusion supported by stronger evidence. Training and clinical governance should reinforce that AI output is decision support, not an automatic replacement for professional judgment.

Patients also deserve clear explanations when AI influences their care. Transparency should include the intended role of the system, its important limitations, and the circumstances in which a human professional will review its recommendations.

The Future of Uncertainty-Aware Healthcare AI

The next generation of healthcare AI may move beyond producing predictions toward systems that actively manage the limits of their own knowledge. Such systems could estimate uncertainty, evaluate the consequences of possible actions, determine whether additional information is worthwhile, and recognize when a decision should be escalated to a healthcare professional.

This development could also support more individualized clinical decision-making. Instead of applying one threshold to every patient, an uncertainty-aware system could account for the patient’s clinical context, the reliability of available measurements, the risks of alternative actions, and the evidence supporting the proposed recommendation. Such personalization would require careful validation to ensure that it improves decisions without creating unjustified differences in care.

Future systems may also incorporate patient preferences more explicitly. Two patients facing similar clinical risks may have different priorities regarding treatment burdens, potential side effects, and quality of life. Their effectiveness will depend on trustworthy uncertainty estimates, evidence-based decision thresholds, continuous performance monitoring, and clear accountability for clinical decisions.

Conclusion: Making Decisions Without Pretending to Know Everything

Clinical Uncertainty Budgets offer a useful way to address one of the most important challenges in healthcare AI: deciding when an imperfect prediction is sufficient to support action. Medical decisions rarely occur under conditions of complete certainty, and waiting for perfect information is not always safe or practical. At the same time, acting on unreliable predictions can expose patients to unnecessary interventions, missed diagnoses, and avoidable harm.

A low-risk recommendation to gather additional information may be justified under substantial uncertainty, while a high-consequence intervention requires stronger evidence and appropriate clinical oversight. The reliability of the model, the quality of the available data, the urgency of the situation, and the consequences of error must all contribute to the decision.

By linking uncertainty to clinical risk, AI systems could become more disciplined about when to recommend action. When to request further evidence, and when to defer to a qualified professional. This approach would not eliminate uncertainty from healthcare. Instead, it would make uncertainty visible, measurable where possible, and central to responsible decision-making.

The ultimate goal is not to build health AI that always has an answer. It is to build health AI that recognizes when its answer is reliable enough to help. When the evidence remains insufficient, and when the safest recommendation is to seek further evaluation.